People who start taking medication soon after the first signs of multiple sclerosis (MS) may have a lower risk of disability later, according to a study published in the July 19, 2023, online issue of Neurology, the medical journal of the American Academy of Neurology.
ICER revises sickle cell gene therapy report, preps to dig into what CMS negotiations might look like
The Boston-based Institute for Clinical and Economic Review, a drug price watchdog, has revised its report on sickle cell gene therapies and is planning a
July 14, 2023